Testimonials

Small Molecules

Biological Therapeutics

New Targets

Diagnostics

Enabling Technology

Antibody Portfolio

Mouse & Cell Line Portfolio

     Mouse by Type

     Mouse by Disease

     Mouse by Phenotype

     Cell Line by Type

     Cell Line by Disease

     View All Mouse Models

     View All Cell Lines

     General Information

Register

p300 cell lines

Relevance : In vitro study of p300 knockout in colon carcinoma cell line; in vitro study of the role of p300 in p53-dependent apoptosis, cellular adhesion and migration.
Description : Somatic knockout of p300 allele
Cell Line Type / Application : Knockout cell line
Species / Origin : Human, derived from HCT116 human colorectal carcinoma cell lines
Growth / Phenotype Keywords : Adhesion properties; invasion; migration
Disease Keywords : Cancer; colorectal carcinoma
Recommended Growth Conditions : Cell lines can be grown in McCoy's 5A medium with 10% FCS
References :

Iyer NG et al, PNAS, 2004, v101 pp7386-7391 PubMed Logo

Krubasik D et al, British Journal of Cancer, 2006, v94 pp1326-1332 PubMed Logo

Notes :

There are three KO p300 KO cell lines (p300 KO Clone D10 (HCT116), p300 KO Clone F5 and p300 KO Clone F2) of the p300 WT (HCT116) cell line.

They are an ideal tool for the study of the effects of p300 knockout on the growth potential, adhesion properties and migration of tumour cells in vitro.

The cell lines are derived from human colorectal carcinoma cell line HCT116, are deficient for p300, a transcriptional cofactor involved in regulating multiple cellular processes including cell cycle regulation, proliferation, differentiation, apoptosis, DNA damage repair and adhesion properties.

The p300 KO lines demonstrate an 'aggressive' cancer phenotype in vitro, with loss of cell-cell adhesion, defects in cell-matrix adhesion, and increased migration through collagen matrices. Experiments should be conducted using two of the three KO cell lines. The parental cell line HCT116 will also be required.

Somatic inactivating mutations are associated with several cancers including breast, colorectal and gastric cancers.


For further information about mouse models from CRT, or to discuss supply or licensing options, please contact us at reagents@cancertechnology.com

Click here for general information on supply, pricing and terms and conditions.